Sara Tehrani

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. doi request reprint Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia
    Sara Tehrani
    Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Stockholm, Sweden
    Thromb Res 126:e225-31. 2010
  2. pmc High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes
    Sara Tehrani
    Division of Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
    Diabetes Care 35:404-8. 2012
  3. ncbi request reprint Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes
    Sara Tehrani
    Division of Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
    Diab Vasc Dis Res 10:483-8. 2013

Detail Information

Publications3

  1. doi request reprint Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia
    Sara Tehrani
    Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Stockholm, Sweden
    Thromb Res 126:e225-31. 2010
    ..In the present study we investigated the effects of lipid-lowering therapy with atorvastatin on fibrin network structure and platelet-derived microparticles in patients with type 1 diabetes and dyslipidemia...
  2. pmc High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes
    Sara Tehrani
    Division of Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
    Diabetes Care 35:404-8. 2012
    ....
  3. ncbi request reprint Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes
    Sara Tehrani
    Division of Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
    Diab Vasc Dis Res 10:483-8. 2013
    ..The present study investigated the effects of lipid-lowering therapy with atorvastatin on skin microvascular function in patients with type 1 diabetes and dyslipidaemia...